Eloxx Pharmaceuticals, Inc.
ELOXOther · Non-accelerated filer<br>Smaller reporting company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $6.4M | $0 | — | — | — |
| Operating income | −$6.4M | −$2.5M | −$17.3M | −$34.4M | −$66.0M | −$33.5M |
| Net income | −$6.0M | −$3.1M | −$17.1M | −$36.1M | −$66.7M | −$34.6M |
| Total assets | $5.3M | $3.0M | $1.7M | $21.1M | $45.1M | $26.5M |
| Total liabilities | $17.2M | $27.3M | $24.3M | $31.8M | $22.8M | $16.2M |
| Equity | −$11.9M | −$24.3M | −$22.6M | −$10.7M | $22.4M | $10.2M |
| EPS (diluted) | $-0.49 | $-0.84 | $-6.63 | $-16.65 | $-38.15 | — |
| Shares out. | 4.8M | 3.5M | 2.2M | 86.7M | 40.2M | 40.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 50.3%
- Return on assets
- −113.8%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 325.9%
- Debt / equity
- —
- Book value / share
- $-2.49
- Revenue growth (YoY)
- −100.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -209.70distress
- Accruals / assets
- 6.3%moderate
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 3 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 19, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Coastlands Capital LpPassive (13G)May 29, 2026
- Domicilium Real Estate Fund Iii LpPassive (13G)May 4, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Coastlands Capital Lp10% owner | May 27, 2026 | J | 1.3M | $0.00 |
| Rubin Steven DDirector | Jan 24, 2026 | Option exercise | 1,875 | — |
| Aggarwal SumitOfficer — President and CEO | Aug 14, 2025 | Option exercise | 196,880 | $0.00 |
| Walts Alan EdmundDirector | Jan 24, 2026 | Option exercise | 1,875 | — |
| Aggarwal SumitDirector | Jan 24, 2025 | Option exercise | 30,000 | $0.00 |
| Rubin Steven DDirector | Jan 24, 2025 | Option exercise | 3,750 | $0.00 |
| Androski LindsayDirector | Jan 24, 2025 | Option exercise | 3,750 | $0.00 |
| Walts Alan EdmundDirector | Jan 24, 2025 | Option exercise | 3,750 | $0.00 |
| Walts Alan EdmundDirector | Oct 16, 2024 | Grant | 12,000 | $0.00 |
| Androski LindsayDirector | Oct 16, 2024 | Grant | 12,000 | $0.00 |
| Rubin Steven DDirector | Oct 16, 2024 | Grant | 12,000 | $0.00 |
| Aggarwal SumitOfficer — PRESIDENT AND CEO | Oct 16, 2024 | Grant | 165,000 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2,052 | 1.0 | 0.0% |
| Apr 30, 2026 | 2,052 | 1.0 | 0.0% |
| Apr 15, 2026 | 2,052 | 1.0 | 0.0% |
| Mar 31, 2026 | 2,052 | 1.0 | 0.0% |
| Mar 13, 2026 | 2,052 | 29.3 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Unregistered equity sale · Modified shareholder rights · Director / officer change · Amended charter or bylawsJun 1, 2026
- Shareholder voteMay 1, 2026
- Director / officer changeAug 12, 2025
- Director / officer changeOct 17, 2024
- Entered a material agreement · New financial obligationJul 16, 2024
- Director / officer changeMar 29, 2024
- Entered a material agreementMar 14, 2024
- Entered a material agreement · Unregistered equity saleJan 9, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-A12BJun 1, 2026
- S-1/AJun 1, 2026
- 8-KJun 1, 2026
- 3Jun 1, 2026
- 3Jun 1, 2026
- 4OWNERSHIP DOCUMENTMay 29, 2026
- SCHEDULE 13G/AMay 29, 2026
- 4May 8, 2026
- 4May 8, 2026
- 4May 8, 2026
- DEF 14CMay 8, 2026
- S-1May 7, 2026
- 10-QMay 5, 2026
- 3May 4, 2026
- SCHEDULE 13GMay 4, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.